Search results for "Acte"

showing 10 items of 9295 documents

Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation.

2019

Introduction: Infections are among the most frequent complications in patients with hematological and oncological diseases. They might be classified as fever of unknown origin and microbiologically or clinically documented infections. Optimal duration of antimicrobial treatment is still unclear in these patients.Areas covered: We provide an overview on the management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation.Expert opinion: Patients with febrile high-risk neutropenia should be treated empirically with an anti-pseudomonal agent such as piperacillin/tazobactam. Several clinical studies support the assumption that the primary antibiotic regime…

0301 basic medicineMicrobiology (medical)medicine.medical_specialtyAntifungal Agents030106 microbiologyNeutropeniaMicrobiologyTazobactam03 medical and health sciencesAntimicrobial Stewardship0302 clinical medicineAnti-Infective AgentsVirologyMedicineHumans030212 general & internal medicineFever of unknown originIntensive care medicineFebrile Neutropeniabusiness.industryDrug Resistance Microbialmedicine.diseaseAntimicrobialDrug Resistance MultipleDiscontinuationAnti-Bacterial AgentsInfectious DiseasesDrug Therapy CombinationbusinessFebrile neutropeniaDe-escalationmedicine.drugPiperacillinExpert review of anti-infective therapy
researchProduct

The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives

2021

INTRODUCTION: The COVID-19 pandemic has dramatically challenged the national health systems worldwide in the last months. Dalbavancin is a novel antibiotic with a long plasmatic half-life and simplified weekly administration regimens, thus representing a promising option for the outpatient treatment of Gram-positive infections and the early discharge of hospitalized patients. Dalbavancin is approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs). Many preliminary data seem to support its use in other indications, such as osteomyelitis, prosthetic joint infections, and infective endocarditis. AREAS COVERED: A search in the literature using validated keyword…

0301 basic medicineMicrobiology (medical)medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)medicine.drug_classProsthetic joint030106 microbiologyAntibioticsGram-Positive Bacterial InfectionABSSSIsMicrobiologyDrug Administration Scheduleosteomyelitis.endocarditi03 medical and health sciencesABSSSIs; COVID-19; dalbavancin; endocarditis; Gram-positive; long-acting; osteomyelitisGram-positive0302 clinical medicineVirologyPandemicAnti-Bacterial AgentmedicineAmbulatory CareAnimalsHumans030212 general & internal medicineIntensive care medicineGram-Positive Bacterial Infectionsbusiness.industryAnimalOsteomyelitisDalbavancinCOVID-19osteomyelitisSkin Diseases Bacteriallong-actingABSSSImedicine.diseaseAnti-Bacterial AgentsInfectious DiseasesInfective endocarditisSkin structureendocarditisosteomyelitiTeicoplaninbusinessdalbavancinHuman
researchProduct

Bactibilia in women affected with diseases of the biliary tract and pancreas. A STROBE guidelines-adherent cross-sectional study in Southern Italy.

2018

Abstract Purpose. Bile is a hepatobiliary lipid-rich sterile solution, and its colonization by microorganisms defines the condition of bactibilia. In this study, we aimed to assess the bile microbiological flora and its potential link with comorbidity in women. Methodology. We performed a microbiologic investigation on 53 female patients with biliopancreatic diseases who granted consent, and we analysed the data using a MATLAB platform. Results. We found that the most frequent disease associated with bactibilia was pancreas head carcinoma (PHC) (P=0.0015), while the least frequent disease was gall bladder carcinoma (GBC) (P=0.0002). The most common microorganisms were Pseudomonas spp. (P&lt…

0301 basic medicineMicrobiology (medical)medicine.medical_specialtyPancreatic diseaseMediterranean dietCross-sectional studyMicrobiologyGastroenterologyBiliary disease03 medical and health sciences0302 clinical medicineInternal medicineGram-Negative BacteriamedicineCarcinomaBileHumansBiliary TractAgedAged 80 and overbusiness.industryMortality rateGeneral MedicineMiddle Agedmedicine.diseaseComorbidityBactibiliaPancreatic Neoplasms030104 developmental biologyBiliary Tract NeoplasmsCross-Sectional StudiesItalyBiliary tract030220 oncology & carcinogenesisFemalebusinessJournal of medical microbiology
researchProduct

Topic Application of the Probiotic Streptococcus dentisani Improves Clinical and Microbiological Parameters Associated With Oral Health

2020

Streptococcus dentisani 7746, isolated from dental plaque of caries-free individuals, has been shown to have several beneficial effects in vitro which could contribute to promote oral health, including an antimicrobial activity against oral pathogens by the production of bacteriocins and a pH buffering capacity through ammonia production. Previous work has shown that S. dentisani was able to colonize the oral cavity for 2–4 weeks after application. The aim of the present work was to evaluate its clinical efficacy by a randomized, double-blind, placebo-controlled parallel group study. Fifty nine volunteers were enrolled in the study and randomly assigned to a treatment or placebo group. The …

0301 basic medicineMicrobiology (medical)medicine.medical_specialtySalivadental plaque030106 microbiologyImmunologylcsh:QR1-502Oral HealthDental CariesOral healthPlaceboDental plaqueMicrobiologyGastroenterologyPlacebo grouplcsh:Microbiologylaw.inventionStreptococcus mutans03 medical and health sciencesProbioticCellular and Infection MicrobiologybacteriocinlawInternal medicinemedicineHumansSalivasalivary flowOriginal Researchbusiness.industryProbioticsStreptococcusAntimicrobialmedicine.disease030104 developmental biologyInfectious DiseasesbusinessprobioticStreptococcus dentisaniFrontiers in Cellular and Infection Microbiology
researchProduct

Evaluation of a mass spectrometry and Vitek 2 combined protocol for rapid identification and susceptibility testing of Enterobacterales directly from…

2020

Abstract Objective The aim was to evaluate a rapid method which would combine identification and susceptibility testing directly from positive blood cultures for Gram-negative bacilli of the Enterobacterales. Material and methods Gram-negative rods from blood cultures were directly identified by MALDI-TOF. Samples with Enterobacterales were selected for direct antimicrobial susceptibility testing by Vitek 2. The results were compared to those obtained with our laboratory's standard method. Results MALDI-TOF directly from blood cultures identified correctly 83% of the samples. Enterobacterales (n = 68) were identified at gender and species level in 85% of blood cultures with a score >1.7. In…

0301 basic medicineMicrobiology (medical)medicine.medical_specialtySusceptibility testing030106 microbiologyAntimicrobial susceptibilityBacteremiaMicrobial Sensitivity Tests03 medical and health sciences0302 clinical medicineSpecies levelEnterobacteriaceaeInternal medicineEnterobacteralesmedicineHumans030212 general & internal medicineProtocol (science)business.industryAnti-Bacterial AgentsRapid identificationCiprofloxacinAmikacinBlood CultureSpectrometry Mass Matrix-Assisted Laser Desorption-Ionizationbusinessmedicine.drugEnfermedades infecciosas y microbiologia clinica (English ed.)
researchProduct

Identification of virulence factors and antibiotic resistance markers using bacterial genomics.

2016

International audience; In recent years, the number of multidrug-resistant bacteria has increased rapidly and several epidemics were signaled in different regions of the world. Faced with this situation that presents a major global public health concern, the development and the use of new and rapid technologies is more than urgent. The use of the next-generation sequencing platforms by microbiologists and infectious disease specialists has allowed great progress in the medical field. Here, we review the usefulness of whole-genome sequencing for the detection of virulence and antibiotic resistance associated genes.

0301 basic medicineMicrobiology (medical)medicine.medical_specialtyVirulence Factors[SDV]Life Sciences [q-bio]030106 microbiologyVirulenceComputational biologyBiologyMicrobiology03 medical and health sciencesAntibiotic resistanceDrug Resistance Multiple BacterialmedicineHumansWhole genome sequencingBacteriaVirulence[ SDV ] Life Sciences [q-bio]business.industryBacterial genomicsPublic healthHigh-Throughput Nucleotide SequencingGenomicsbiology.organism_classification3. Good healthBiotechnology[SDV] Life Sciences [q-bio]Infectious disease (medical specialty)Spectrometry Mass Matrix-Assisted Laser Desorption-IonizationbusinessGenome BacterialBacteria
researchProduct

Selection of New Probiotics for Endometrial Health

2019

Microbiota is a crucial player in gynecologic health, in which bacteria can shift to a dysbiotic state triggering a pathogenic process. Based on an ecological understanding of the problem, the aim of this study is to select a potential probiotic strain to improve female reproductive tract based on its capacity to initially lower pH and to promote the reduction of pathogenic bacteria. Based on this rationale, strain Lactobacillus rhamnosus BPL005 was initially selected for its capacity to reduce in vitro pH levels and produce organic acids. Subsequently, strain L. rhamnosus BPL005 (CECT 8800) was demonstrated to have a protective role on endometrial infections in an in vitro model of bacteri…

0301 basic medicineMicrobiology (medical)pathogen inhibition030106 microbiologyImmunologyCarboxylic Acidslcsh:QR1-502Atopobium vaginaemedicine.disease_causeReproductive Tract InfectionsMicrobiologylcsh:MicrobiologyStreptococcus agalactiaeMicrobiologylaw.invention03 medical and health sciencesPropionibacterium acnesProbioticLactobacillus rhamnosuslawAntibiosismedicineHumansGardnerella vaginalisendometrial healthPropionibacterium acnesL. rhamnosus BPL005 (CECT 8800)Cells CulturedbiologyLacticaseibacillus rhamnosusMicrobiotaProbioticsfood and beveragesEpithelial CellsPathogenic bacteriaGenitalia FemaleHydrogen-Ion Concentrationbiology.organism_classificationGardnerella vaginalisActinobacteria030104 developmental biologyInfectious DiseasesStreptococcus agalactiaegynecological pathogensFemaleBacteriaprobioticFrontiers in Cellular and Infection Microbiology
researchProduct

Directed evolution of a Mycobacteriophage

2019

This article belongs to the Special Issue Bacteriophages: Alternatives to Antibiotics and Beyond.

0301 basic medicineMicrobiology (medical)phage therapyPhage therapyPhage therapyMycobacteriophagemedicine.medical_treatment030106 microbiologymycobacteriophagesMycobacterium smegmatismedicine.disease_causeBiochemistryMicrobiologyArticle03 medical and health sciencesAntibiotic resistancemedicinePharmacology (medical)General Pharmacology Toxicology and Pharmaceuticsdirected evolutionGeneticsMycobacteriophagesbiologyMycobacterium smegmatislcsh:RM1-950Pathogenic bacteriaMycobacteriophagesbiology.organism_classificationDirected evolution3. Good health030104 developmental biologyInfectious Diseaseslcsh:Therapeutics. PharmacologyLytic cycle<i>Mycobacterium smegmatis</i>Directed evolution
researchProduct

Phage Therapy in Gastrointestinal Diseases

2020

Gastrointestinal tract microbiota plays a key role in the regulation of the pathogenesis of several gastrointestinal diseases. In particular, the viral fraction, composed essentially of bacteriophages, influences homeostasis by exerting a selective pressure on the bacterial communities living in the tract. Gastrointestinal inflammatory diseases are mainly induced by bacteria, and have risen due to the emergence of antibiotic resistant strains. In the lack of effective treatments, phage therapy has been proposed as a clinical alternative to restore intestinal eubiosis, thanks to its immunomodulatory and bactericidal effect against bacterial pathogens, such as Clostridioides difficile in ulce…

0301 basic medicineMicrobiology (medical)phage therapyPhage therapymedicine.medical_treatment030106 microbiologymicrobiomeReviewBiologymedicine.disease_causeMicrobiologyMicrobiologyBacteriophage03 medical and health sciencesAntibiotic resistancebacteriophageVirologymedicineHuman viromeMicrobiomelcsh:QH301-705.5Escherichia coliviromeGastrointestinal tractdysbiosismedicine.diseasebiology.organism_classification030104 developmental biologylcsh:Biology (General)gastrointestinal tractDysbiosisMicroorganisms
researchProduct

Probiotic Potential of Leuconostoc pseudomesenteroides and Lactobacillus Strains Isolated From Yaks

2018

The purpose of this study was to evaluate the antibacterial activity and safety of bacterias with probiotic potential isolated from free-ranging Tibetan yaks in high altitude regions of Tibet. For this purpose, one Leuconostoc pseudomesenteroides strain (named P1) and two Lactobacillus johnsonii and Lactobacillus mucosae strains (named LY1 and LY2), respectively, were isolated from fecal samples of Tibetan yaks. The antibacterial activity of the isolates was studied using Escherichia coli (E. coli ATCC 25922), Staphylococcus aureus (S. aureus ATCC 26112), and Salmonella enteritidis (S. enteritidis NCTC 13349) as indicator pathogens. The results showed that LY1 had high antibacterial efficac…

0301 basic medicineMicrobiology (medical)safetySalmonella enteritidis030106 microbiologyLactobacillus mucosaelcsh:QR1-502Leuconostoc pseudomesenteroidesBiologymedicine.disease_causeMicrobiologyLeuconostoc pseudomesenteroideslcsh:MicrobiologyMicrobiologylaw.invention03 medical and health sciencesProbioticantibacterial activitylawLactobacillusmedicineEscherichia coliLactobacillus johnsoniiOriginal Researchbiology.organism_classification030104 developmental biologyyaksStaphylococcus aureusLactobacillus strainsFrontiers in Microbiology
researchProduct